|
|
BlossomHill Therapeutics Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/17/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization756.11 mln
Float1.43 mln
1-Year Forecast
32.20
Attractive
Key Fundamentals
EPS-3.41
ROIC-469
ROA-44.90
EBITDA, mln-63.58
EV / EBITDA-7.44
EV / EBIT-7.39
Financial Strength
1-Year Target Price32.20
Short Ratio0.18
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
24.69% |
99
/ 100
 |
| 1 Month |
66.58% |
99
/ 100
|
|
| |
